ABIGAIL COBB: Open Payments
NPI 1558838532 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 35 payments from 9 companies in 2025. Trend: 2023 $874 · 2024 $682 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $237 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| ABIOMED | 3 | $54 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| PFIZER INC. | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $31 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Boston Scientific Corporation | 1 | $14 |
Products named: Wegovy, LEQVIO, Ozempic, VERQUVO, Kerendia, VYNDAQEL, SAPIEN 3 Ultra RESILIA, AREXVY.
Industry payments across GA — which companies pay providers there.
